Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study

A prospective cohort study

Heather Greenlee, Marilyn L. Kwan, Isaac J. Ergas, Garrett Strizich, Janise M. Roh, Allegra T. Wilson, Marion Lee, Karen J. Sherman, Christine B. Ambrosone, Dawn L. Hershman, Alfred I. Neugut, Lawrence H. Kushi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Vitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.Methods: We prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28% non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.Results: Most women used vitamin/mineral supplements before (84%) and after (82%) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2%) reported initiating a vitamin/mineral following diagnosis, 46.3% discontinuing a vitamin/mineral, 65.6% using a vitamin/mineral continuously, and only 7.2% not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2%), vitamin D (32.01%), vitamin B6 (12.3%) and magnesium (11.31%); the most commonly discontinued supplements were multivitamins (17.14%), vitamin C (15.97%) and vitamin E (45.62%). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).Conclusions: In this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.

Original languageEnglish (US)
Article number382
JournalBMC Cancer
Volume14
Issue number1
DOIs
StatePublished - May 29 2014
Externally publishedYes

Fingerprint

Vitamins
Minerals
Cohort Studies
Prospective Studies
Breast Neoplasms
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Vitamin B 6
Segmental Mastectomy
Vitamin E
Vitamin D
Vegetables
Magnesium
Ascorbic Acid
Life Style
Fruit
Logistic Models
Demography
Calcium
Education
Drug Therapy

Keywords

  • Breast cancer
  • Cohort studies
  • Dietary supplements
  • Multivitamins
  • Vitamins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics
  • Medicine(all)

Cite this

Greenlee, H., Kwan, M. L., Ergas, I. J., Strizich, G., Roh, J. M., Wilson, A. T., ... Kushi, L. H. (2014). Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: A prospective cohort study. BMC Cancer, 14(1), [382]. https://doi.org/10.1186/1471-2407-14-382

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study : A prospective cohort study. / Greenlee, Heather; Kwan, Marilyn L.; Ergas, Isaac J.; Strizich, Garrett; Roh, Janise M.; Wilson, Allegra T.; Lee, Marion; Sherman, Karen J.; Ambrosone, Christine B.; Hershman, Dawn L.; Neugut, Alfred I.; Kushi, Lawrence H.

In: BMC Cancer, Vol. 14, No. 1, 382, 29.05.2014.

Research output: Contribution to journalArticle

Greenlee, H, Kwan, ML, Ergas, IJ, Strizich, G, Roh, JM, Wilson, AT, Lee, M, Sherman, KJ, Ambrosone, CB, Hershman, DL, Neugut, AI & Kushi, LH 2014, 'Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: A prospective cohort study', BMC Cancer, vol. 14, no. 1, 382. https://doi.org/10.1186/1471-2407-14-382
Greenlee, Heather ; Kwan, Marilyn L. ; Ergas, Isaac J. ; Strizich, Garrett ; Roh, Janise M. ; Wilson, Allegra T. ; Lee, Marion ; Sherman, Karen J. ; Ambrosone, Christine B. ; Hershman, Dawn L. ; Neugut, Alfred I. ; Kushi, Lawrence H. / Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study : A prospective cohort study. In: BMC Cancer. 2014 ; Vol. 14, No. 1.
@article{e7f377c6ad164b9d9f6967fb6ab9fc60,
title = "Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: A prospective cohort study",
abstract = "Background: Vitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.Methods: We prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28{\%} non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.Results: Most women used vitamin/mineral supplements before (84{\%}) and after (82{\%}) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2{\%}) reported initiating a vitamin/mineral following diagnosis, 46.3{\%} discontinuing a vitamin/mineral, 65.6{\%} using a vitamin/mineral continuously, and only 7.2{\%} not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2{\%}), vitamin D (32.01{\%}), vitamin B6 (12.3{\%}) and magnesium (11.31{\%}); the most commonly discontinued supplements were multivitamins (17.14{\%}), vitamin C (15.97{\%}) and vitamin E (45.62{\%}). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).Conclusions: In this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.",
keywords = "Breast cancer, Cohort studies, Dietary supplements, Multivitamins, Vitamins",
author = "Heather Greenlee and Kwan, {Marilyn L.} and Ergas, {Isaac J.} and Garrett Strizich and Roh, {Janise M.} and Wilson, {Allegra T.} and Marion Lee and Sherman, {Karen J.} and Ambrosone, {Christine B.} and Hershman, {Dawn L.} and Neugut, {Alfred I.} and Kushi, {Lawrence H.}",
year = "2014",
month = "5",
day = "29",
doi = "10.1186/1471-2407-14-382",
language = "English (US)",
volume = "14",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study

T2 - A prospective cohort study

AU - Greenlee, Heather

AU - Kwan, Marilyn L.

AU - Ergas, Isaac J.

AU - Strizich, Garrett

AU - Roh, Janise M.

AU - Wilson, Allegra T.

AU - Lee, Marion

AU - Sherman, Karen J.

AU - Ambrosone, Christine B.

AU - Hershman, Dawn L.

AU - Neugut, Alfred I.

AU - Kushi, Lawrence H.

PY - 2014/5/29

Y1 - 2014/5/29

N2 - Background: Vitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.Methods: We prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28% non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.Results: Most women used vitamin/mineral supplements before (84%) and after (82%) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2%) reported initiating a vitamin/mineral following diagnosis, 46.3% discontinuing a vitamin/mineral, 65.6% using a vitamin/mineral continuously, and only 7.2% not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2%), vitamin D (32.01%), vitamin B6 (12.3%) and magnesium (11.31%); the most commonly discontinued supplements were multivitamins (17.14%), vitamin C (15.97%) and vitamin E (45.62%). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).Conclusions: In this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.

AB - Background: Vitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.Methods: We prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28% non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.Results: Most women used vitamin/mineral supplements before (84%) and after (82%) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2%) reported initiating a vitamin/mineral following diagnosis, 46.3% discontinuing a vitamin/mineral, 65.6% using a vitamin/mineral continuously, and only 7.2% not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2%), vitamin D (32.01%), vitamin B6 (12.3%) and magnesium (11.31%); the most commonly discontinued supplements were multivitamins (17.14%), vitamin C (15.97%) and vitamin E (45.62%). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).Conclusions: In this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.

KW - Breast cancer

KW - Cohort studies

KW - Dietary supplements

KW - Multivitamins

KW - Vitamins

UR - http://www.scopus.com/inward/record.url?scp=84902553127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902553127&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-14-382

DO - 10.1186/1471-2407-14-382

M3 - Article

VL - 14

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 382

ER -